Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A

被引:250
作者
Jankowska, Anna M. [1 ]
Makishima, Hideki [1 ]
Tiu, Ramon V. [1 ,2 ]
Szpurka, Hadrian [1 ]
Huang, Yun [3 ]
Traina, Fabiola [1 ]
Visconte, Valeria [1 ]
Sugimoto, Yuka [1 ]
Prince, Courtney [1 ]
O'Keefe, Christine [1 ]
Hsi, Eric D. [4 ]
List, Alan [5 ]
Sekeres, Mikkael A. [2 ]
Rao, Anjana [3 ]
McDevitt, Michael A. [6 ]
Maciejewski, Jaroslaw P. [1 ,2 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Hematol Oncol & Blood Disorders, Leukemia Program, Cleveland, OH 44106 USA
[3] La Jolla Inst Allergy & Immunol, San Diego, CA USA
[4] Cleveland Clin, Dept Clin Pathol, Cleveland, OH 44106 USA
[5] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[6] Johns Hopkins Univ, Sch Med, Div Hematol & Hematol Malignancy, Baltimore, MD USA
关键词
WORLD-HEALTH-ORGANIZATION; HISTONE METHYLTRANSFERASE; FREQUENT ALTERATIONS; UNIPARENTAL DISOMY; SOMATIC MUTATIONS; IDH2; MUTATIONS; TET2; GENE; CLASSIFICATION; REVEALS; H3K27;
D O I
10.1182/blood-2010-10-311019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic myelomonocytic leukemia (CMML), a myelodysplastic/myeloproliferative neoplasm, is characterized by monocytic proliferation, dysplasia, and progression to acute myeloid leukemia. CMML has been associated with somatic mutations in diverse recently identified genes. We analyzed 72 well-characterized patients with CMML (N + 52) and CMML-derived acute myeloid leukemia (N + 20) for recurrent chromosomal abnormalities with the use of routine cytogenetics and single nucleotide polymorphism arrays along with comprehensive mutational screening. Cytogenetic aberrations were present in 46% of cases, whereas single nucleotide polymorphism array increased the diagnostic yield to 60%. At least 1 mutation was found in 86% of all cases; novel UTX, DNMT3A, and EZH2 mutations were found in 8%, 10%, and 5.5% of patients, respectively. TET2 mutations were present in 49%, ASXL1 in 43%, CBL in 14%, IDH1/2 in 4%, KRAS in 7%, NRAS in 4%, and JAK2 V617F in 1% of patients. Various mutant genotype combinations were observed, indicating molecular heterogeneity in CMML. Our results suggest that molecular defects affecting distinct pathways can lead to similar clinical phenotypes. (Blood. 2011;118(14):3932-3941)
引用
收藏
页码:3932 / 3941
页数:10
相关论文
共 49 条
[1]   The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration [J].
Abdel-Wahab, O. ;
Kilpivaara, O. ;
Patel, J. ;
Busque, L. ;
Levine, R. L. .
LEUKEMIA, 2010, 24 (09) :1656-1657
[2]   UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development [J].
Agger, Karl ;
Cloos, Paul A. C. ;
Christensen, Jesper ;
Pasini, Diego ;
Rose, Simon ;
Rappsilber, Juri ;
Issaeva, Irina ;
Canaani, Eli ;
Salcini, Anna Elisabetta ;
Helin, Kristian .
NATURE, 2007, 449 (7163) :731-U10
[3]  
[Anonymous], **NON-TRADITIONAL**
[4]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[5]   Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation [J].
Chou, Wen-Chien ;
Hou, Hsin-An ;
Chen, Chien-Yuan ;
Tang, Jih-Luh ;
Yao, Ming ;
Tsay, Woei ;
Ko, Bor-Shen ;
Wu, Shang-Ju ;
Huang, Shang-Yi ;
Hsu, Szu-Chun ;
Chen, Yao-Chang ;
Huang, Yen-Ning ;
Chang, Yi-Chang ;
Lee, Fen-Yu ;
Liu, Ming-Chi ;
Liu, Chia-Wen ;
Tseng, Mei-Hsuan ;
Huang, Chi-Fei ;
Tien, Hwei-Fang .
BLOOD, 2010, 115 (14) :2749-2754
[6]   Cancer-associated IDH1 mutations produce 2-hydroxyglutarate [J].
Dang, Lenny ;
White, David W. ;
Gross, Stefan ;
Bennett, Bryson D. ;
Bittinger, Mark A. ;
Driggers, Edward M. ;
Fantin, Valeria R. ;
Jang, Hyun Gyung ;
Jin, Shengfang ;
Keenan, Marie C. ;
Marks, Kevin M. ;
Prins, Robert M. ;
Ward, Patrick S. ;
Yen, Katharine E. ;
Liau, Linda M. ;
Rabinowitz, Joshua D. ;
Cantley, Lewis C. ;
Thompson, Craig B. ;
Heiden, Matthew G. Vander ;
Su, Shinsan M. .
NATURE, 2009, 462 (7274) :739-U52
[7]   Mutation in TET2 in Myeloid Cancers [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Della Valle, Veronique ;
James, Chloe ;
Trannoy, Severine ;
Masse, Aline ;
Kosmider, Olivier ;
Le Couedic, Jean-Pierre ;
Robert, Fabienne ;
Alberdi, Antonio ;
Lecluse, Yann ;
Plo, Isabelle ;
Dreyfus, Francois J. ;
Marzac, Christophe ;
Casadevall, Nicole ;
Lacombe, Catherine ;
Romana, Serge P. ;
Dessen, Philippe ;
Soulier, Jean ;
Viguie, Franck ;
Fontenay, Michaela ;
Vainchenker, William ;
Bernard, Olivier A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301
[8]   250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies [J].
Dunbar, Andrew J. ;
Gondek, Lukasz P. ;
O'Keefe, Christine L. ;
Makishima, Hideki ;
Rataul, Manjot S. ;
Szpurka, Hadrian ;
Sekeres, Mikkael A. ;
Wang, Xiao Fei ;
McDevitt, Michael A. ;
Maciejewski, Jaroslaw P. .
CANCER RESEARCH, 2008, 68 (24) :10349-10357
[9]   Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders [J].
Ernst, Thomas ;
Chase, Andrew J. ;
Score, Joannah ;
Hidalgo-Curtis, Claire E. ;
Bryant, Catherine ;
Jones, Amy V. ;
Waghorn, Katherine ;
Zoi, Katerina ;
Ross, Fiona M. ;
Reiter, Andreas ;
Hochhaus, Andreas ;
Drexler, Hans G. ;
Duncombe, Andrew ;
Cervantes, Francisco ;
Oscier, David ;
Boultwood, Jacqueline ;
Grand, Francis H. ;
Cross, Nicholas C. P. .
NATURE GENETICS, 2010, 42 (08) :722-U109
[10]   Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].
Figueroa, Maria E. ;
Abdel-Wahab, Omar ;
Lu, Chao ;
Ward, Patrick S. ;
Patel, Jay ;
Shih, Alan ;
Li, Yushan ;
Bhagwat, Neha ;
Vasanthakumar, Aparna ;
Fernandez, Hugo F. ;
Tallman, Martin S. ;
Sun, Zhuoxin ;
Wolniak, Kristy ;
Peeters, Justine K. ;
Liu, Wei ;
Choe, Sung E. ;
Fantin, Valeria R. ;
Paietta, Elisabeth ;
Lowenberg, Bob ;
Licht, Jonathan D. ;
Godley, Lucy A. ;
Delwel, Ruud ;
Valk, Peter J. M. ;
Thompson, Craig B. ;
Levine, Ross L. ;
Melnick, An .
CANCER CELL, 2010, 18 (06) :553-567